Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Passage BIO, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 42 | 41 | −1 |
| Shares | 36.3M | 35.1M | −1.26M (−3.5%) |
| Value | $12.8M | $13.0M | +$203.0K (+1.6%) |
New holders (5)
Institutions that held Passage BIO, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 247,682 | $99.1K | 0.00% |
| Ritholtz Wealth Management | 25,392 | $10.2K | 0.00% |
| Two Sigma Securities, LLC | 11,724 | $4.69K | 0.00% |
| Raymond James Financial Inc | 6,391 | $2.56K | 0.00% |
| Mid-American Wealth Advisory Group, Inc. | 32 | $13 | 0.00% |
Sold out (6)
Institutions that held Passage BIO, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Shay Capital LLC | 146,717 | $51.8K |
| Squarepoint Ops LLC | 64,141 | $22.6K |
| HighTower Advisors, LLC | 18,346 | $6.48K |
| MAI Capital Management | 4,000 | $1.41K |
| Harbour Investments, Inc. | 60 | $21 |
| Farther Finance Advisors, LLC | 50 | $19 |